SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000885590-19-000035
Filing Date
2019-11-04
Accepted
2019-11-04 07:38:39
Documents
16
Period of Report
2019-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-q3x2019pressrelease.htm   iXBRL 8-K 53406
2 EXHIBIT 99.1 ex991-q3x2019.htm EX-99.1 919649
8 bauschlogoa02.jpg GRAPHIC 7860
  Complete submission text file 0000885590-19-000035.txt   1179153

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20191104.xsd EX-101.SCH 4585
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20191104_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20191104_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20191104_lab.xml EX-101.LAB 27205
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20191104_pre.xml EX-101.PRE 14099
14 EXTRACTED XBRL INSTANCE DOCUMENT a8k-q3x2019pressrelease_htm.xml XML 4520
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 191188261
SIC: 2834 Pharmaceutical Preparations